Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (281-290 of 345) with videos related to

Pageof 35
Sort By:
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Journal of Neuropathology and Experimental Neurology|December 22, 2010
Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29Richard S Bedlack, Angela Genge, Anthony A Amato, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Muscle & Nerve|April 10, 2020
Guidelines on clinical presentation and management of nondystrophic myotoniasBas C Stunnenberg, Samantha LoRusso, W David Arnold, et al.
Annals of Clinical and Translational Neurology|August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravisJae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.
Arthritis and Rheumatism|November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trialChester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
Journal of the Peripheral Nervous System : JPNS|January 5, 2011
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practiceKenneth C Gorson, Ivo N van Schaik, Ingemar S J Merkies, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Muscle & Nerve|November 3, 2009
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experienceMamatha Pasnoor, Gil I Wolfe, Sharon Nations, et al.
Pageof 35

Showing results (281-290 of 345) with videos related to

Sort By:
Pageof 35
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Journal of Neuropathology and Experimental Neurology|December 22, 2010
Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29Richard S Bedlack, Angela Genge, Anthony A Amato, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Muscle & Nerve|April 10, 2020
Guidelines on clinical presentation and management of nondystrophic myotoniasBas C Stunnenberg, Samantha LoRusso, W David Arnold, et al.
Annals of Clinical and Translational Neurology|August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravisJae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.
Arthritis and Rheumatism|November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trialChester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
Journal of the Peripheral Nervous System : JPNS|January 5, 2011
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practiceKenneth C Gorson, Ivo N van Schaik, Ingemar S J Merkies, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Muscle & Nerve|November 3, 2009
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experienceMamatha Pasnoor, Gil I Wolfe, Sharon Nations, et al.
Pageof 35